NSC61610

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP500538943
CAS500538-94-3
Molecular Weight548.59
Description≥98% (HPLC)
SolubilityDMSO: 2 mg/mL, clear
Assay≥98% (HPLC)
Coloroff-white to purple
Formpowder
Size5MG, 25MG
Storage Conditions2-8°C

1An N,N-Bis(benzimidazolylpicolinoyl)piperazine (BT-11): A Novel Lanthionine Synthetase C-Like 2-Based Therapeutic for Inflammatory Bowel Disease

Adria Carbo, Richard D Gandour, Raquel Hontecillas, Noah Philipson, Aykut Uren, Josep Bassaganya-Riera

J Med Chem. 2016 Nov 23;59(22):10113-10126.

PMID: 27933891

Read More

1Computational Modeling-Based Discovery of Novel Classes of Anti-Inflammatory Drugs That Target Lanthionine Synthetase C-like Protein 2

Pinyi Lu, Raquel Hontecillas, William T Horne, Adria Carbo, Monica Viladomiu, Mireia Pedragosa, David R Bevan, Stephanie N Lewis, Josep Bassaganya-Riera

PLoS One. 2012;7(4):e34643.

PMID: 22509338

Read More

1Identification of Small Molecule Inhibitors of Interleukin-18

Brian Krumm, Xiangzhi Meng, Yan Xiang, Junpeng Deng

Sci Rep. 2017 Mar 28;7(1):483.

PMID: 28352119

Read More

1Lanthionine Synthetase C-Like 2 Modulates Immune Responses to Influenza Virus Infection

Andrew Leber, Josep Bassaganya-Riera, Nuria Tubau-Juni, Victoria Zoccoli-Rodriguez, Pinyi Lu, Victoria Godfrey, Shiv Kale, Raquel Hontecillas

Front Immunol. 2017 Feb 21;8:178.

PMID: 28270815

Read More

1Lanthionine Synthetase Component C-like Protein 2: A New Drug Target for Inflammatory Diseases and Diabetes

Pinyi Lu, Raquel Hontecillas, Casandra W Philipson, Josep Bassaganya-Riera

Curr Drug Targets. 2014 Jun;15(6):565-72.

PMID: 24628287

Read More

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

Follow us on

Copyright © 2022 Alfa Chemistry. All rights reserved.